|
Market Closed -
NYSE
00:00:00 05/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.030 USD | +1.98% |
|
0.00% | -38.32% |
| 10-29 | Lineage Cell Therapeutics Provides Update On ReSonance Program For Hearing Loss | CI |
| 10-01 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| Market Cap | 260M 232M 213M 193M 364M 24.62B 372M 2.54B 1.02B 13.03B 978M 957M 41.28B | P/E 2026 * |
-17.2x | P/E 2027 * | -8.03x |
|---|---|---|---|---|---|
| Enterprise Value | 260M 232M 213M 193M 364M 24.62B 372M 2.54B 1.02B 13.03B 978M 957M 41.28B | EV / Sales 2026 * |
17.1x | EV / Sales 2027 * | 15.5x |
| Free-Float |
95.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
|
Tradegate
| BT3 | Real-time | |
|
Deutsche Boerse AG
| BT3 | Delayed | |
|
Börse Stuttgart
| BT3 | Delayed | |
|
Boerse Muenchen
| BT3 | Real-time |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | +1.98% | ||
| Current month | +3.00% | ||
| 1 month | +10.72% | ||
| 3 months | -7.21% | ||
| 6 months | -32.68% | ||
| Current year | -38.32% |
| 1 week | 0.98 |  | 1.06 |
| 1 month | 0.89 | | 1.06 |
| Current year | 0.88 | | 1.98 |
| 1 year | 0.88 | | 1.99 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 17/09/2018 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 14/11/2022 |
Priyantha Herath
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 01/07/2009 |
Deborah Andrews
BRD | Director/Board Member | 68 | 11/04/2014 |
Michael Mulroy
CHM | Chairman | 60 | 27/04/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 A | Free | Director | 125,000 | 0.0501% | ||
| 7/1/26 A | Broadwood Capital, Inc.
| Free | Company | 125,000 | 0.0501% | |
| 7/1/26 A | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.98% | 0.00% | -47.45% | -11.97% | 255M | |
| +10.00% | +5.18% | +54.35% | +71.20% | 60.57B | |
| +1.44% | +4.06% | +22.70% | +101.03% | 55.51B | |
| +3.32% | +4.11% | +14.82% | +75.04% | 55.22B | |
| +0.46% | -2.86% | +23.34% | +33.77% | 43.27B | |
| +6.42% | +3.20% | +21.14% | +105.56% | 40.36B | |
| +2.82% | +7.24% | +236.59% | +801.17% | 41.63B | |
| -3.79% | +19.39% | +91.90% | +77.13% | 33.29B | |
| +5.32% | +6.04% | +20.27% | +52.98% | 32.27B | |
| +5.32% | +15.84% | -40.93% | +342.66% | 22.91B | |
| Average | +3.33% | +4.33% | +39.67% | +164.86% | 38.53B | |
| Weighted average by Cap. | +3.72% | +4.06% | +51.51% | +169.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.19M 13.54M 12.42M 11.28M 21.21M 1.44B 21.7M 148M 59.49M 760M 57.03M 55.81M 2.41B | 16.83M 15M 13.76M 12.5M 23.5M 1.59B 24.04M 164M 65.91M 842M 63.19M 61.84M 2.67B |
| Net income | -22.64M -20.17M -18.5M -16.81M -31.61M -2.14B -32.33M -221M -88.65M -1.13B -84.98M -83.16M -3.59B | -34.44M -30.69M -28.14M -25.58M -48.08M -3.25B -49.18M -336M -135M -1.72B -129M -127M -5.46B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/11/26 | $1.030 | +1.98% | 959,017 |
| 03/11/26 | $1.010 | 0.00% | 919,890 |
| 02/11/26 | $1.010 | +1.00% | 1,722,924 |
| 30/10/26 | $1.000 | -2.91% | 1,166,443 |
| 29/10/26 | $1.030 | -0.96% | 937,733 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
